Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Take 30 percent off your entire order. ☄ Disclaimer ☄* Offer valid 11/23/15 - 11/25/15. 30% discount applies to all Medical Reference and Textbooks, PDF, ePub & VST eBooks. This offer is not valid on Clinics Review Articles (individual issues and subscriptions), Journals, and Nursing and Health Profession Textbooks, Institutional Video Series, HESI Products, Kindle or Nook e-books, Pageburst titles, ClinicalKey packages, mobile apps, medical clothing or accessories, bulk or previous purchases, clearance titles, or in combination with any other promotion. Offer only valid for purchases by individual customers in U.S., Mexico, South and Central America and the Caribbean from Enter promotional code BBV4E16514 at checkout to receive your discount. This offer expires on November 25, 2015.

Lung Cancer

An International Journal for Lung Cancer and other thoracic malignancies

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.

Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.

Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Manuscripts should be submitted online at click here and the instructions on this site should be closely followed.

View all Oncology titles

Editor Information

    R.A. Stahel

Impact Factor

* 2011 Journal Citation ReportsĀ®, published by Thomson Reuters

Customer Reviews

Lung Cancer
  • Journal
  • Imprint: ELSEVIER
  • ISSN: 01695002
  • 2014 Impact Factor: 3.958*